Draft Guidance Gives Clarity on Rare Pediatric Disease Priority Reviews

August 7, 2019

Young patients facing certain rare diseases or conditions such as fatal blood diseases and cystic fibrosis could see more drug treatments, the Food and Drug Administration (FDA) announced on July 29 (84 Fed. Reg., 36,929).

Related Stories